UnitedHealth Group Inc (UNH) Holdings Reduced by Assetmark Inc.

Assetmark Inc. lowered its holdings in UnitedHealth Group Inc (NYSE:UNH) by 43.6% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 66,616 shares of the healthcare conglomerate’s stock after selling 51,411 shares during the quarter. Assetmark Inc.’s holdings in UnitedHealth Group were worth $13,047,000 as of its most recent filing with the SEC.

Other institutional investors have also bought and sold shares of the company. BlackRock Inc. raised its position in shares of UnitedHealth Group by 1.2% during the second quarter. BlackRock Inc. now owns 69,430,416 shares of the healthcare conglomerate’s stock worth $12,873,786,000 after acquiring an additional 796,654 shares during the last quarter. Vanguard Group Inc. raised its position in shares of UnitedHealth Group by 2.5% during the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after acquiring an additional 1,588,516 shares during the last quarter. FMR LLC raised its position in shares of UnitedHealth Group by 2.1% during the second quarter. FMR LLC now owns 56,101,668 shares of the healthcare conglomerate’s stock worth $10,402,371,000 after acquiring an additional 1,168,324 shares during the last quarter. Alliancebernstein L.P. raised its position in shares of UnitedHealth Group by 2.3% during the second quarter. Alliancebernstein L.P. now owns 7,906,936 shares of the healthcare conglomerate’s stock worth $1,466,104,000 after acquiring an additional 174,290 shares during the last quarter. Finally, TIAA CREF Investment Management LLC raised its position in shares of UnitedHealth Group by 3.9% during the second quarter. TIAA CREF Investment Management LLC now owns 5,882,427 shares of the healthcare conglomerate’s stock worth $1,090,720,000 after acquiring an additional 223,524 shares during the last quarter. 86.09% of the stock is currently owned by institutional investors.

Shares of UnitedHealth Group Inc (UNH) opened at $243.35 on Monday. UnitedHealth Group Inc has a fifty-two week low of $156.49 and a fifty-two week high of $244.35. The stock has a market capitalization of $235,290.00, a PE ratio of 22.72, a price-to-earnings-growth ratio of 1.42 and a beta of 0.66. The company has a quick ratio of 0.70, a current ratio of 0.73 and a debt-to-equity ratio of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The company had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. During the same period in the prior year, the company earned $2.11 earnings per share. The company’s revenue for the quarter was up 9.5% compared to the same quarter last year. sell-side analysts predict that UnitedHealth Group Inc will post 12.52 EPS for the current fiscal year.

A number of equities research analysts have recently weighed in on the company. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 target price for the company in a research report on Saturday. Argus boosted their target price on UnitedHealth Group to $270.00 and gave the stock a “buy” rating in a research report on Thursday. Credit Suisse Group boosted their target price on UnitedHealth Group from $252.00 to $260.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 17th. Oppenheimer boosted their target price on UnitedHealth Group from $260.00 to $240.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 17th. Finally, Cantor Fitzgerald boosted their target price on UnitedHealth Group to $280.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 17th. Two investment analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the company. The company has an average rating of “Buy” and an average price target of $243.22.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of the stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total value of $1,250,536.00. Following the completion of the sale, the director now directly owns 61,137 shares in the company, valued at $13,652,503.47. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Kenneth Irwin Shine sold 457 shares of the stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total value of $96,440.71. The disclosure for this sale can be found here. Insiders sold 33,655 shares of company stock valued at $7,469,083 over the last 90 days. Corporate insiders own 0.89% of the company’s stock.

WARNING: This report was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this report on another site, it was illegally copied and reposted in violation of US and international trademark and copyright law. The correct version of this report can be viewed at https://www.dispatchtribunal.com/2018/01/22/unitedhealth-group-inc-unh-holdings-reduced-by-assetmark-inc.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply